Literature DB >> 9622546

6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.

X F Pei1, T H Gupta, B Badio, W L Padgett, J W Daly.   

Abstract

A series of tropane derivatives, related in structure to baogongteng A (1), an alkaloid from a Chinese herb, were synthesized. 6beta-Acetoxynortropane (5) had weak affinity (Ki 22 microM) for central (M1) muscarinic receptors in a [3H]quinuclidinyl benzilate binding assay but had extremely high affinity (Ki 2.6 nM) and selectivity for M2-muscarinic receptors expressed in CHO cells. It had 13-fold lower affinity for M4-receptors, 260-fold lower affinity for M3-receptors, and 8200-fold lower affinity for M1-receptors expressed in CHO cells. The 6beta-carbomethoxy analogue (14) of baogongteng A had only weak affinity for M2-muscarinic receptors, as did 6beta-carbomethoxynortropane (13) and 6beta-acetoxytropane (4). In transfected CHO cells, 6beta-acetoxynortropane (5) was an agonist at M2-receptors, based on a GTP-elicited decrease in affinity, and a full agonist with an IC50 of 11 nM at M4-receptors, based on inhibition of cyclic AMP accumulation, while being a full agonist at M1-receptors with an EC50 of 23 nM and a partial agonist at M3-receptors with an EC50 of 3.6 nM, based in both cases on stimulation of phosphoinositide breakdown. All of the 16 tropane derivatives had weak affinities for central alpha4beta2-nicotinic receptors with 6beta-carbomethoxynortropane (13) having the highest affinity, which was still 150-fold less than that of nicotine. 6beta-Acetoxynortropane (5) represents a potent muscarinic agonist with apparent selectivity toward M2-receptors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9622546     DOI: 10.1021/jm9705115

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  Inhibition of Human Prostate and Bladder Smooth Muscle Contraction, Vasoconstriction of Porcine Renal and Coronary Arteries, and Growth-Related Functions of Prostate Stromal Cells by Presumed Small Molecule Gαq/11 Inhibitor, YM-254890.

Authors:  Alexander Tamalunas; Amin Wendt; Florian Springer; Anna Ciotkowska; Beata Rutz; Ruixiao Wang; Ru Huang; Yuhan Liu; Heiko Schulz; Stephan Ledderose; Giuseppe Magistro; Christian G Stief; Martin Hennenberg
Journal:  Front Physiol       Date:  2022-05-23       Impact factor: 4.755

Review 2.  Nicotinic agonists, antagonists, and modulators from natural sources.

Authors:  John W Daly
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

3.  Synthesis and in vitro evaluation of novel nortropane derivatives as potential radiotracers for muscarinic m(2) receptors.

Authors:  Remco J J Knol; Jan C van den Bos; Anton G M Janssen; Kora de Bruin; Berthe L F van Eck-Smit; Jan Booij
Journal:  Int J Mol Imaging       Date:  2011-06-13

4.  Picotamide inhibits a wide spectrum of agonist-induced smooth muscle contractions in porcine renal interlobar and coronary arteries.

Authors:  Bingsheng Li; Ru Huang; Ruixiao Wang; Yuhan Liu; Christian G Stief; Martin Hennenberg
Journal:  Pharmacol Res Perspect       Date:  2021-05

5.  Inhibition of neurogenic contractions in renal arteries and of cholinergic contractions in coronary arteries by the presumed inhibitor of ADP-ribosylation factor 6, NAV2729.

Authors:  Ru Huang; Bingsheng Li; Alexander Tamalunas; Raphaela Waidelich; Christian G Stief; Martin Hennenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-02-10       Impact factor: 3.000

Review 6.  Multitargeting nature of muscarinic orthosteric agonists and antagonists.

Authors:  Jaromir Myslivecek
Journal:  Front Physiol       Date:  2022-09-06       Impact factor: 4.755

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.